C. Martin Daniel's most recent trade in Deciphera Pharmaceuticals Inc was a trade of 38,900 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 15, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Deciphera Pharmaceuticals Inc | Martin C. Daniel | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 38,900 | 38,900 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | Daniel C. Martin | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 9,725 | 57,385 (0%) | 0% | 0 | Common Stock | |
| Deciphera Pharmaceuticals Inc | C. Martin Daniel | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 15.62 per share. | 15 Feb 2024 | 2,267 | 55,118 (0%) | 0% | 15.6 | 35,405 | Common Stock |
| Deciphera Pharmaceuticals Inc | Martin Daniel C. | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 14.47 per share. | 16 Jan 2024 | 1,624 | 47,660 (0%) | 0% | 14.5 | 23,499 | Common Stock |
| Deciphera Pharmaceuticals Inc | C. Martin Daniel | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 5,576 | 51,011 (0%) | 0% | - | Common Stock | |
| Deciphera Pharmaceuticals Inc | C. Martin Daniel | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 15.37 per share. | 12 Dec 2023 | 1,727 | 49,284 (0%) | 0% | 15.4 | 26,539 | Common Stock |
| Deciphera Pharmaceuticals Inc | Daniel C. Martin | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 14.40 per share. | 16 Jun 2023 | 1,238 | 58,413 (0%) | 0% | 14.4 | 17,829 | Common Stock |
| Deciphera Pharmaceuticals Inc | Daniel C. Martin | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 44,600 | 44,600 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | Daniel C. Martin | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 11,151 | 59,540 (0%) | 0% | 0 | Common Stock | |
| Deciphera Pharmaceuticals Inc | Daniel C. Martin | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 15.10 per share. | 15 Feb 2023 | 1,159 | 58,381 (0%) | 0% | 15.1 | 17,500 | Common Stock |
| Deciphera Pharmaceuticals Inc | Daniel C. Martin | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 21.24 per share. | 17 Jan 2023 | 1,603 | 48,389 (0%) | 0% | 21.2 | 34,050 | Common Stock |
| Deciphera Pharmaceuticals Inc | Daniel C. Martin | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 10.75 per share. | 16 Jun 2022 | 1,311 | 49,521 (0%) | 0% | 10.7 | 14,093 | Common Stock |
| Deciphera Pharmaceuticals Inc | Daniel C. Martin | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 9.05 per share. | 16 Feb 2022 | 1,146 | 48,668 (0%) | 0% | 9.0 | 10,371 | Common Stock |
| Deciphera Pharmaceuticals Inc | Daniel C. Martin | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 54,667 | 54,667 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | Daniel C. Martin | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 13,667 | 49,814 (0%) | 0% | 0 | Common Stock |